Kun Mi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Antimicrobial Resistance

Respiratory Tract

Highly Efficient

Staphylococcus Aureus

Top Venues

Antibiotics (Basel, Switzerland)

PLoS computational biology

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Lan Zhang, Xiaoyuan Tian, Lei Sun, Kun Mi, Ru Wang, Fengying Gong, Lingli Huang
Bacterial Efflux Pump Inhibitors Reduce Antibiotic Resistance. Pharmaceutics 16 (2) (2024)
Lan Zhang, Xiaoyuan Tian, Lei Sun, Kun Mi, Ru Wang, Fengying Gong, Lingli Huang
Bacterial Efflux Pump Inhibitors Reduce Antibiotic Resistance. Pharmaceutics 16 (2) (2024)
Kun Mi, Lei Sun, Yixuan Hou, Xin Cai, Kaixiang Zhou, Wenjin Ma, Xiangyue Xu, Yuanhu Pan, Zhenli Liu, Lingli Huang
A physiologically based pharmacokinetic model to optimize the dosage regimen and withdrawal time of cefquinome in pigs. PLoS computational biology 19 (8) (2023)
Lei Sun, Kun Mi, Yixuan Hou, Tianyi Hui, Lan Zhang, Yanfei Tao, Zhenli Liu, Lingli Huang
Pharmacokinetic and Pharmacodynamic Drug-Drug Interactions: Research Methods and Applications. Metabolites 13 (8) (2023)
Yixuan Hou, Kun Mi, Lei Sun, Kaixiang Zhou, Lei Wang, Lan Zhang, Zhenli Liu, Lingli Huang
The Application of Hollow Fiber Cartridge in Biomedicine. Pharmaceutics 14 (7) (2022)
Kun Mi, Shanju Pu, Yixuan Hou, Lei Sun, Kaixiang Zhou, Wenjin Ma, Xiangyue Xu, Meixia Huo, Zhenli Liu, Changqing Xie, Wei Qu, Lingli Huang
Optimization and Validation of Dosage Regimen for Ceftiofur against Pasteurella multocida in Swine by Physiological Based Pharmacokinetic-Pharmacodynamic Model. International journal of molecular sciences 23 (7) (2022)
Kun Mi, Kaixiang Zhou, Lei Sun, Yixuan Hou, Wenjin Ma, Xiangyue Xu, Meixia Huo, Zhenli Liu, Lingli Huang
Application of Semi-Mechanistic Pharmacokinetic and Pharmacodynamic Model in Antimicrobial Resistance. Pharmaceutics 14 (2) (2022)
Zihui Xu, Anxiong Huang, Xun Luo, Peng Zhang, Lingli Huang, Xu Wang, Kun Mi, Shiwei Fang, Xiao Huang, Jun Li, Zonghui Yuan, Haihong Hao
Exploration of Clinical Breakpoint of Danofloxacin for Glaesserella parasuis in Plasma and in PELF. Antibiotics (Basel, Switzerland) 10 (7) (2021)
Kaixiang Zhou, Meixia Huo, Wenjin Ma, Kun Mi, Xiangyue Xu, Samah Attia Algharib, Shuyu Xie, Lingli Huang
Application of a Physiologically Based Pharmacokinetic Model to Develop a Veterinary Amorphous Enrofloxacin Solid Dispersion. Pharmaceutics 13 (5) (2021)
Kun Mi, Da Sun, Mei Li, Haihong Hao, Kaixiang Zhou, Zhenli Liu, Zonghui Yuan, Lingli Huang
Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China. Pathogens (Basel, Switzerland) 10 (2) (2021)
Kaixiang Zhou, Aimei Liu, Wenjin Ma, Lei Sun, Kun Mi, Xiangyue Xu, Samah Attia Algharib, Shuyu Xie, Lingli Huang
Apply a Physiologically Based Pharmacokinetic Model to Promote the Development of Enrofloxacin Granules: Predict Withdrawal Interval and Toxicity Dose. Antibiotics (Basel, Switzerland) 10 (8) (2021)
Kun Mi, Mei Li, Lei Sun, Yixuan Hou, Kaixiang Zhou, Haihong Hao, Yuanhu Pan, Zhenli Liu, Changqing Xie, Lingli Huang
Determination of Susceptibility Breakpoint for Cefquinome against Streptococcus suis in Pigs. Antibiotics (Basel, Switzerland) 10 (8) (2021)